Development of novel methods to enable robust comparison of real-world Progression Free Survival (PFS) and Clinical Trial PFS in Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/238/31/24

Funding

  • Janssen Research & Development, LLC (C2023019267 // 1U01FD007937-01)
  • Food and Drug Administration (C2023019267 // 1U01FD007937-01)